• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹水的存在影响肝静脉压力梯度对肝硬化患者早期再出血的预测价值。

The Presence of Ascites Affects the Predictive Value of HVPG on Early Rebleeding in Patients with Cirrhosis.

作者信息

Liu Chuan, Shao Ruoyang, Wang Sining, Wang Guangchuan, Wang Lifen, Zhang Mingyan, Liu Yanna, Liang Mingkai, Li Xiaoguo, Kang Ning, Wang Jitao, Xu Dan, Mao Hua, Zhang Chunqing, Qi Xiaolong

机构信息

Department of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou 510000, China.

Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510000, China.

出版信息

Gastroenterol Res Pract. 2020 Nov 24;2020:1329857. doi: 10.1155/2020/1329857. eCollection 2020.

DOI:10.1155/2020/1329857
PMID:33299405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7710417/
Abstract

BACKGROUND AND AIMS

Gastroesophageal variceal bleeding is a serious complication of portal hypertension in cirrhotic patients and could be predicted by hepatic venous pressure gradient (HVPG). However, whether the presence of ascites affects the prognostic value of HVPG for patients with acute variceal bleeding is still unknown. This retrospective study is aimed at investigating the influence of ascites on predictive performance of HVPG for early rebleeding in cirrhotic patients with acute variceal bleeding.

METHODS

In this retrospective study, a total of 148 patients with cirrhosis hospitalized for acute variceal bleeding who underwent HVPG measurement and endoscopic variceal ligation (EVL) for the prevention of rebleeding were included. The receiver operating characteristic curve (ROC) and logistical regression method were employed to analyze the predictive performance of HVPG for early rebleeding. The locally weighted scatterplot smoothing approach was adopted to assess the monotonicity between bleeding risk and HVPG.

RESULTS

A significantly higher HVPG level was observed in patients with early rebleeding compared to patients without rebleeding in the nonascites cohort. When using HVPG to predict early rebleeding, there was a lower area under curve in the ascites cohort compared to the nonascites cohort. HVPG was recognized as a risk factor for early rebleeding by a logistic regression model only in the nonascites cohort. An overall monotonicity in the trend of change in HVPG and risk for early rebleeding was observed in the nonascites cohort solely.

CONCLUSION

The predictive value of HVPG for early rebleeding in patients with cirrhosis that developed acute variceal bleeding is hindered by the presence of ascites.

摘要

背景与目的

胃食管静脉曲张出血是肝硬化患者门静脉高压的严重并发症,可通过肝静脉压力梯度(HVPG)进行预测。然而,腹水的存在是否会影响HVPG对急性静脉曲张出血患者的预后价值仍不清楚。这项回顾性研究旨在探讨腹水对肝硬化急性静脉曲张出血患者HVPG预测早期再出血性能的影响。

方法

在这项回顾性研究中,共纳入148例因急性静脉曲张出血住院的肝硬化患者,这些患者接受了HVPG测量和内镜下静脉曲张结扎术(EVL)以预防再出血。采用受试者工作特征曲线(ROC)和逻辑回归方法分析HVPG对早期再出血的预测性能。采用局部加权散点图平滑法评估出血风险与HVPG之间的单调性。

结果

在非腹水队列中,早期再出血患者的HVPG水平明显高于未再出血患者。当使用HVPG预测早期再出血时,腹水队列的曲线下面积低于非腹水队列。仅在非腹水队列中,逻辑回归模型将HVPG识别为早期再出血的危险因素。仅在非腹水队列中观察到HVPG变化趋势与早期再出血风险之间的总体单调性。

结论

腹水的存在阻碍了HVPG对发生急性静脉曲张出血的肝硬化患者早期再出血的预测价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a8/7710417/4d6f5192b188/GRP2020-1329857.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a8/7710417/6378bca81183/GRP2020-1329857.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a8/7710417/0cc1abd6a60c/GRP2020-1329857.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a8/7710417/4d6f5192b188/GRP2020-1329857.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a8/7710417/6378bca81183/GRP2020-1329857.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a8/7710417/0cc1abd6a60c/GRP2020-1329857.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a8/7710417/4d6f5192b188/GRP2020-1329857.003.jpg

相似文献

1
The Presence of Ascites Affects the Predictive Value of HVPG on Early Rebleeding in Patients with Cirrhosis.腹水的存在影响肝静脉压力梯度对肝硬化患者早期再出血的预测价值。
Gastroenterol Res Pract. 2020 Nov 24;2020:1329857. doi: 10.1155/2020/1329857. eCollection 2020.
2
The predictive value of baseline hepatic venous pressure gradient for variceal rebleeding in cirrhotic patients receiving secondary prevention.基线肝静脉压力梯度对接受二级预防的肝硬化患者静脉曲张再出血的预测价值。
Ann Transl Med. 2020 Feb;8(4):91. doi: 10.21037/atm.2019.12.143.
3
Hepatic venous pressure gradient and rebleeding risk of patients with nonalcoholic steatohepatitis cirrhosis after variceal bleeding.非酒精性脂肪性肝炎肝硬化患者静脉曲张出血后肝静脉压力梯度与再出血风险
Front Med (Lausanne). 2023 Jul 25;10:1224506. doi: 10.3389/fmed.2023.1224506. eCollection 2023.
4
Hepatic venous pressure gradient is a useful predictor in guiding treatment on prevention of variceal rebleeding in cirrhosis.肝静脉压力梯度是指导肝硬化患者预防静脉曲张再出血治疗的有用预测指标。
Int J Clin Exp Med. 2015 Oct 15;8(10):19709-16. eCollection 2015.
5
[Clinical application of hepatic venous pressure gradient to predict early bleeding after esophageal variceal ligation].肝静脉压力梯度在预测食管静脉曲张结扎术后早期出血中的临床应用
Zhonghua Gan Zang Bing Za Zhi. 2015 Jan;23(1):50-4. doi: 10.3760/cma.j.issn.1007-3418.2015.01.012.
6
Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG.对肝静脉压力梯度(HVPG)较高的肝硬化患者进行静脉曲张出血的二级预防。
Scand J Gastroenterol. 2016 Dec;51(12):1502-1506. doi: 10.1080/00365521.2016.1193218. Epub 2016 Jul 5.
7
A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding.基于肝硬化和 HVPG 分期的预后策略改善静脉曲张出血后的风险分层。
Hepatology. 2020 Oct;72(4):1353-1365. doi: 10.1002/hep.31125. Epub 2020 Jul 6.
8
Use of portal pressure studies in the management of variceal haemorrhage.门静脉压力研究在静脉曲张出血管理中的应用。
World J Gastrointest Endosc. 2012 Jul 16;4(7):281-9. doi: 10.4253/wjge.v4.i7.281.
9
Complications of cirrhosis. I. Portal hypertension.肝硬化的并发症。I. 门静脉高压
J Hepatol. 2000;32(1 Suppl):141-56. doi: 10.1016/s0168-8278(00)80422-5.
10
[Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].[韩国肝硬化患者肝静脉压力梯度的测量:与肝硬化状态、静脉曲张及腹水的关系]
Korean J Hepatol. 2008 Jun;14(2):150-8. doi: 10.3350/kjhep.2008.14.2.150.

引用本文的文献

1
Serum ascites albumin gradient in predicting the severity of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.血清腹水白蛋白梯度在预测由吡咯里西啶生物碱引起的肝窦阻塞综合征严重程度中的作用
Clin Exp Hepatol. 2025 Jun;11(2):152-159. doi: 10.5114/ceh.2025.151628. Epub 2025 Jun 26.
2
Correlation of Hepatic Venous Pressure Gradient Level With Clinical and Endoscopic Parameters in Decompensated Chronic Liver Disease.失代偿期慢性肝病患者肝静脉压力梯度水平与临床及内镜参数的相关性
Cureus. 2023 Dec 27;15(12):e51154. doi: 10.7759/cureus.51154. eCollection 2023 Dec.

本文引用的文献

1
Vascular syndromes in liver cirrhosis.肝硬化中的血管综合征
Clin J Gastroenterol. 2019 Oct;12(5):387-397. doi: 10.1007/s12328-019-00956-0. Epub 2019 Apr 12.
2
Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension.CT 血管造影虚拟肝静脉压力梯度(CHESS 1601):一项用于门静脉高压症无创诊断的前瞻性多中心研究。
Radiology. 2019 Feb;290(2):370-377. doi: 10.1148/radiol.2018180425. Epub 2018 Nov 20.
3
Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study.
肝硬化临床显著性门静脉高压症的放射组学特征的建立和验证(CHESS1701):一项前瞻性多中心研究。
EBioMedicine. 2018 Oct;36:151-158. doi: 10.1016/j.ebiom.2018.09.023. Epub 2018 Sep 27.
4
Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension.新兴的非侵入性方法用于门静脉高压的诊断和监测。
Lancet Gastroenterol Hepatol. 2018 Oct;3(10):708-719. doi: 10.1016/S2468-1253(18)30232-2.
5
Liver Imaging in Precision Medicine.精准医学中的肝脏成像
EBioMedicine. 2018 Jun;32:1-2. doi: 10.1016/j.ebiom.2018.05.017. Epub 2018 May 18.
6
Clinical states of cirrhosis and competing risks.肝硬化的临床状态和竞争风险。
J Hepatol. 2018 Mar;68(3):563-576. doi: 10.1016/j.jhep.2017.10.020. Epub 2017 Oct 27.
7
New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.代偿期和失代偿期肝硬化的临床病程和分层的新概念。
Hepatol Int. 2018 Feb;12(Suppl 1):34-43. doi: 10.1007/s12072-017-9808-z. Epub 2017 Jul 5.
8
Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention.将我们目前对腹水管理的认识转化为针对肝硬化和液体潴留患者的新疗法。
Dig Dis. 2017;35(4):402-410. doi: 10.1159/000456595. Epub 2017 May 3.
9
Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.肝硬化门静脉高压出血:风险分层、诊断及管理:美国肝病研究协会2016年实践指南
Hepatology. 2017 Jan;65(1):310-335. doi: 10.1002/hep.28906. Epub 2016 Dec 1.
10
Hepatic venous pressure gradient is a useful predictor in guiding treatment on prevention of variceal rebleeding in cirrhosis.肝静脉压力梯度是指导肝硬化患者预防静脉曲张再出血治疗的有用预测指标。
Int J Clin Exp Med. 2015 Oct 15;8(10):19709-16. eCollection 2015.